相关实验视频

Updated: Sep 19, 2025

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

尼古丁加剧了子的节律失常,由慢性阻塞性肺部疾病引发的右心室外流通道

Chao-Shun Chan^1,2, Feng-Zhi Lin^3,4, Yao-Chang Chen⁴

¹Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Journal of cellular and molecular medicine

|June 19, 2025

概括

尼古丁在慢性阻塞性肺病 (COPD) 中通过增加右心室外流通道 (RVOT) 的电气和结构变化,使心室低心率 (VT) 恶化. 这些效应被特定的药物治疗扭转了.

科学领域:

心脏病学心脏病学
肺部医学肺部医学
药理学药理学是指药理学的学科.

背景情况:

香烟烟雾含有尼古丁,是心室低心率 (VT) 的已知危险因素.
慢性阻塞性肺病 (COPD) 和右心室外流通道 (RVOT) 分别是静脉瘤的主要风险因素和来源.
了解尼古丁在COPD相关静脉治疗中的作用对于患者管理至关重要.

研究的目的:

在COPD引起的RVOT变化的背景下研究尼古丁的节律失常效应.
探索特定信号通路抑制剂 (H89,KN93,KB-R7943) 在缓解尼古丁加剧的静脉瘤方面的潜力.

主要方法:

在子中使用人类白细胞弹性酶诱导COPD.
太基减速和异二醇的使用可诱导静脉动.
使用尼古丁的治疗方法,H89,KN93和KB-R7943.
补丁电生理学和马森三色染色用于纤维化评估.

主要成果:

与对照组相比,COPD子的静脉瘤发病率较高,RVOT纤维化增加.
尼古丁暴露在子中加剧了静脉瘤和增加了COPD纤维化.
药物治疗 (H89,KN93,KB-R7943) 在COPD和尼古丁治疗的COPD组中抑制了静脉动.
尼古丁改变了COPDRVOT肌细胞中的作用电位,L型Ca2+电流,NCX电流和晚期Na+电流.

结论:

慢性肺炎通过电气和结构重塑以及通过PKA,CaMKII和NCX通路的调节失调来加剧RVOT VT.
尼古丁通过进一步恶化这些电气和结构变化,在COPD的设置中显著加剧了VT.

关键词:

慢性阻塞性肺病慢性阻塞性肺病尼古丁是一种尼古丁.右心室外流管的流出管道腹腔动脉短心症是什么意思

更多相关视频

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

相关概念视频

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Mechanism of Cardiac Arrhythmias

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.